Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
Teva CEO Says Drugmaker Will Fight U.S. Price-Fixing Charges (2)
teva News and latest stories | The Jerusalem Post
Teva Pharmaceutical's Sales Slump 18% - WSJ
teva News and latest stories | The Jerusalem Post
Three-Stock Lunch: AMD, HAS & TEVA
Teva reaches $4.25B deal to settle opioid lawsuits | The Hill
Teva bought the pharm, and now it may have bought the farm | The Times of Israel
Buy Teva Pharmaceuticals amid positive news, Bernstein says
Teva Pharmaceutical Announces Restructuring Plan, But Analysts Questions Whether It Will Succeed | Stock News & Stock Market Analysis - IBD
Teva to pay $523 mln to New York as it looks to move past opioid lawsuits | Reuters
TEVA: Can Teva Pharmaceutical Stock Continue to Rebound in 2021?
Teva made smart decision to move to us: Allergan CEO
teva News and latest stories | The Jerusalem Post
Teva Pharm expects to start paying U.S. opioid settlement in 2023 - CEO
teva News and latest stories | The Jerusalem Post
Watch CNBC's full interview with Teva Pharmaceuticals CEO Kare Schultz - YouTube
Jury finds Teva Pharmaceuticals fueled opioid epidemic in New York State
Allergan, Teva to pay $54M in San Francisco opioid lawsuit | AP News
Teva Pharmaceuticals responsible for fueling opioid crisis, New York jury finds - JURIST - News
Short interest in Teva Pharmaceutical Industries Limited (NYSE:TEVA) has decreased significantly. - Best Stocks
Teva Pharmaceutical Industries (TEVA) Stock Price, News & Info | The Motley Fool
In The News: Teva, Superfeet, Red Wing - Footwear Insight
Teva ponies up $420M to settle with investors who said company hid price-fixing scheme | Fierce Pharma
Teva CEO Kåre Schultz discusses company's latest quarter and opioid settlement
Teva Pharmaceutical to Replace CEO Kare Schultz - WSJ
